Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Internal Medicine (Tokyo, Japan)|November 21, 2017
Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 RearrangementKenji Tokunaga, Ayako Yamamura, Shikiko Ueno, et al.Experimental Hematology & Oncology|April 25, 2015
Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1Shiho Fujiwara, Naoko Wada, Yawara Kawano, et al.Biochemical and Biophysical Research Communications|March 29, 2017
A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivoNao Nishimura, Shinya Endo, Shikiko Ueno, et al.International Journal of Hematology|March 17, 2016
Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroidsShiho Fujiwara, Hiromi Mochinaga, Hirotomo Nakata, et al.Oncology Letters|April 5, 2018
Bufalin induces DNA damage response under hypoxic condition in myeloma cellsEri Fujii, Yuki Inada, Misaki Kakoki, et al.International Journal of Oncology|July 7, 2012
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomideYawara Kawano, Shiho Fujiwara, Naoko Wada, et al.Nature Genetics|May 18, 2004
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1Frank Rosenbauer, Katharina Wagner, Jeffery L Kutok, et al.Cancer Science|August 27, 2016
An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphomaHasita Horlad, Chaoya Ma, Hiromu Yano, et al.Biochemical and Biophysical Research Communications|November 14, 2018
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cellsShinya Endo, Nao Nishimura, Yawara Kawano, et al.Biochemical and Biophysical Research Communications|December 15, 2015
Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cellsShinya Endo, Masayuki Amano, Nao Nishimura, et al.Pageof 5